Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets

Overview of attention for article published in Journal of Neuroinflammation, September 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 8 news stories from 8 outlets.

Article authored by acclaimed experts in neuro-inflammation, and leaders at the forefront of inflammasome research at…

Article authored by acclaimed experts in neuro-inflammation, and leaders at the forefront of inflammasome research at…

WESTON, Fla., Sept. 8, 2020 /PRNewswire/ --. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in…

WESTON, Fla., Sept. 8, 2020 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.